Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.04 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |